This study investigates the effectiveness, safety, and simplicity of Vaginally Assisted Laparoscopic Sacrohysteropexy (VALSH) using Prolene mesh for the treatment of utero‐vaginal prolapse. By focusing on these aspects, the research aims to evaluate the procedure's viability as a minimally invasive surgical option. Conducted at a tertiary care center, this study involved a sample size of 29 patients who underwent VALSH surgery. The procedure was executed in three phases: initial laparoscopic, followed by vaginal and concluding with a laparoscopic approach. The Prolene mesh was affixed vaginally to the posterior aspect of the cervix and laparoscopically to the sacral promontory. This repositioned the uterus and cervix closer to their normal anatomical locations. Participants were women aged between 22 to 39 years, selected based on specific inclusion and exclusion criteria. The study spanned from 2015 to 2023. One‐year follow‐up data revealed that the patients experienced symptomatic relief, no sexual dysfunction and retained fertility. However, two patients encountered a recurrence of uterovaginal prolapse within six months post‐surgery. VALSH emerges as an innovative minimally invasive technique for treating uterovaginal prolapse, demonstrating a significant safety margin and satisfactory outcomes 12 months after surgery. Furthermore, it effectively conserves the uterus and preserves fertility, marking it as a promising option for patients seeking to maintain reproductive potential.
Sandhya Bhattad, Gauri Dank, Rucha Dhokte and Jyotsna Kshirsagar. Vaginally Assisted Laparoscopic Sacro‐Hysteropexy (VALSH) for Uterine Prolapse A Study at a Tertiary Care Center.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.5.528.532
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.5.528.532